Han‐Yu Weng
Papers
2
Total Citations
9
H-Index
2
About
Han-Yu Weng is a leading urologic oncologist whose research focuses on optimizing surgical management of upper tract urothelial carcinoma (UTUC), a malignancy with high prevalence in Taiwan. His major contributions center on comparing outcomes of open, laparoscopic, and robotic nephroureterectomy with bladder cuff excision, particularly for challenging T3T4 locally advanced disease. In a landmark 2024 multi-center retrospective study (5 citations), he demonstrated that minimally invasive approaches can achieve comparable oncologic outcomes to open surgery in these high-risk patients—a finding that challenges prevailing surgical dogma. Weng also spearheaded Taiwan’s first nationwide collaborative analysis of segmental ureterectomy for UTUC (4 citations), providing critical evidence supporting organ-sparing surgery for selected mid- and distal ureteral tumors in endemic regions. His work has directly shaped clinical guidelines by validating less radical surgical options without compromising cancer control. With over 9 citations across these two pivotal studies, Weng’s research addresses a critical gap in UTUC management, offering surgeons evidence-based guidance for tailoring treatment to tumor stage and location. His collaborative, population-level approach underscores his commitment to improving outcomes in high-incidence populations.
Research Focus
Key Achievements
Top Papers
- 1
- 2